An OCD Prevention Programme for at Risk Adults
ConditionObsessive-Compulsive Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBabes-Bolyai University
About this trial
The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of tertiary prevention.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
clinically diagnosed OCD
current psychiatric/psychotherapeutic treatment
personality disorder diagnosis
suicidal ideation
Trial design
Design model
Parallel
Treatments tested in this trial
Prevention
BehavioralA cognitive-behavioural prevention programme.
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: PreventionExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Change from baseline in OCD symptoms on the OCI-R after the intervention
The OCI-R is a validated self-report instrument assessing OCD symptoms. Possible scores range from 0 to 72. Change = end of intervention score - baseline score
Time frame
Baseline and Week 22
Change from baseline in depressive symptoms on the PHQ-9 after the intervention
The PHQ-9 is a validated self-report instrument assessing depressive symptoms. Possible scores range from 0 to 27. Change = end of intervention score - baseline score
Time frame
Baseline and Week 23
Change from baseline in anxiety symptoms on the GAD-7 after the intervention
The GAD-7 is a validated self-report instrument assessing anxiety symptoms. Possible scores range from 0 to 21. Change = end of intervention score - baseline score
Time frame
Baseline and Week 2Secondary outcomes
1
Change from baseline in experiential avoidance on the EAQ after the intervention
The EAQ is a validated self-report instrument assessing experiential avoidance. Possible scores range from 15 to 90. Change = end of intervention score - baseline score
Time frame
Baseline and Week 22
Change from baseline in cognitive distortions on the OBQ-44 after the intervention
The OBQ-44 is a validated self-report instrument assessing cognitive distortions in OCD. Possible scores range from 7 to 308. Change = end of intervention score - baseline score
Time frame
Baseline and Week 23
Change from baseline in uncertainty intolerance on the IUS after the intervention
The IUS is a validated self-report instrument assessing intolerance of uncertainty. Possible scores range from 27 to 135. Change = end of intervention score - baseline score
Time frame
Baseline and Week 24
Change from baseline in resilience on the RSA after the intervention
The RSA is a validated self-report instrument assessing resilience in adults. Possible scores range from 43 to 215. Change = end of intervention score - baseline score
Time frame
Baseline and Week 2Other outcomes
1
Change from baseline in life quality on the WHOQOL-BREF after the intervention
The WHOQOL-BREF is a validated self-report instrument assessing life quality in adults. Change = end of intervention score - baseline score
Time frame
Baseline and Week 22
Change from baseline in irrationality on the ATQ after the intervention
The ABS-AV is a validated self-report instrument assessing irrationality in adults. Possible scores range from 24 to 120 Change = end of intervention score - baseline score
Time frame
Baseline and Week 23
Change from baseline in global health on the GHQ-12 after the intervention
The GHQ-12 is a validated self-report instrument assessing global health in adults. Possible scores range from 0 to 36. Change = end of intervention score - baseline score
Time frame
Baseline and Week 2Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Babes-Bolyai University
Lead sponsor
Romanian National Authority for Scientific Research
Collaborator
Source ClinicalTrials.gov